Advanced SearchNewsfeedFollowed Companies

Roche's Competitors, Revenue, Number of Employees, Funding and Acquisitions

Roche discovers, develops and provides diagnostic and therapeutic products and services.

Roche's headquarters is in Basel... Read more

Annual Revenue

Employees

Severin Schwan's photo - CEO of Roche

CEO

Severin Schwan

CEO Approval Rating

65/100

OVERVIEW

Founded:

1896

Headquarters:

Basel, Basel-Country

Status:

PublicSIX Swiss ExchangeROG

Industry Sector:

Biotechnology

SIC Code:

2836NAICS listing »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Johnson & Johnson a competitor of Roche?

I don't know

Trending News for Roche and Roche's Competitors

April 3, 2020

Reuters

Novartis, Incyte join repurposing wave to give Jakavi a trial run in COVID-19

Novartis and Incyte plan to test their drug Jakavi in patients with coronavirus-caused COVID-19, join... See more »

April 3, 2020

Seeking Alpha

FDA's OKs new use of Acceleron and Bristol-Myers Squibb's luspatercept

See more »

Today 5:06 AM

Pharmabiz

Pfizer's oncology biosimilar, Ruxience receives European approval to treat certain cancers & autoimmune conditions

Pfizer announced that the European Commission (EC) has approved Ruxience (rituximab), a monoclonal an... See more »

Competitive Analysis

TOP COMPETITORS OR ALTERNATIVES

Novartis is seen as one of Roche's top competitors. Novartis was founded in Basel, Basel-City} in 1996. Novartis is in the Pharmaceuticals industry. Compared to Roche, Novartis generates $15.8B less revenue.

Merck is Roche's #2 competitor. Merck was founded in 1891, and its headquarters is in Kenilworth, New Jersey. Merck is in the Pharmaceuticals field. Merck has 27,000 fewer employees than Roche.

Bristol Myers Squibb is Roche's #3 rival. Bristol Myers Squibb is headquartered in New York, New York, and was founded in 1858. Like Roche, Bristol Myers Squibb also competes in the Biotechnology industry. Bristol Myers Squibb generates 41% the revenue of Roche.

RANK

COMPANY

LEADERSHIP

CEO SCORE

EMPLOYEES

TOTAL FUNDING

REVENUE

Severin Schwan

CEO

- -
98,000
$0
$63.3B
1

Vasant Narasimhan

CEO

90/100
118,393
- -
$47.4B
2

Kenneth C. Frazier

Chairman & CEO

77/100
69,000
- -
$46.8B
3

Giovanni Caforio

Chairman & CEO

66/100
23,300
- -
$26.1B
4

Alex Gorsky

Chairman & CEO

63/100
135,100
- -
$82.1B
5

David A. Ricks

Chairman & CEO

65/100
38,680
- -
$22.3B
6

Emma Walmsley

CEO

66/100
99,827
- -
$44.3B
7

Albert Bourla

Chairman & CEO

70/100
92,400
- -
$51.8B
8

Umang Vohra

CEO

59/100
26,719
- -
$2.2B
9

Robert B. Ford

CEO

77/100
103,000
$6.9M
$31.9B
10

Omar Ishrak

Chairman & CEO

98/100
86,000
- -
$31.1B
The top 10 competitors in Roche's competitive set are Novartis, Merck, Bristol Myers Squibb, Johnson & Johnson, Eli Lilly, GSK, Pfizer, Cipla, Abbott and Medtronic. Together they have raised over 6.9M between their estimated 778.2K employees. Roche has 98,000 employees and is ranked 5th among it's top 10 competitors. The top 10 competitors average 80,947.

Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$63.3B

Roche's revenue is the ranked 2nd among it's top 10 competitors. The top 10 competitors average 40.8B. Over the last three quarters, Roche's revenue has grown by 4%. Specifically, in Q4 2019's revenue was $16.7B; in Q3 2019, it was $15.7B; in Q2 2019, it was $16B.

Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Promedior, Inc.

Nov 2019

Source »
$390M
Promedior is a clinical-stage biotechnology company that develops and commercializes novel therapeutics for the treatment of fibrotic disorders.
Spark Therapeutics, Inc.

Feb 2019

Source »
$4.3B
Spark Therapeutics develops gene therapies for the treatment of hemophilia and neurodegenerative diseases.
Tusk Therapeutics Ltd.

Sep 2018

Source »
$81.9M
Tusk Therapeutics develops and commercializes therapeutic antibodies for the treatment of cancer.
Flatiron Health, Inc.

Feb 2018

Source »
$1.9B
Flatiron Health is a healthcare technology company that focuses on accelerating cancer research through clinical data management.
Ignyta, Inc.

Dec 2017

Source »
$1.7B
Ignyta develops and commercializes targeted molecule therapies for the treatment of cancer.

These are all the companies that Roche has acquired. Roche has acquired 18 companies and its latest acquisition was Promedior, Inc. in Nov 2019. Promedior is a clinical-stage biotechnology company that develops and commercializes novel therapeutics for the treatment of fibrotic disorders.

Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Amunix is a biotechnology firm that develops and commercializes potent immune-activating biotherapeutics to treat patients with solid tumor cancers.
$40M
Jan 09, 2020
Equity
-
Biodesy develops a novel system to analyze real-time protein function for research and clinical applications.
$20M
Sep 09, 2018
Series C
-
Second Genome is a clinical-stage pharmaceutical company that focuses on developing microbiome-based therapeutics for the treatment of chronical diseases and illness.
$8.4M
Jul 12, 2016
Series B
-
Purigen Biosystems develops a transformative platform that automates the process of extracting, enriching and quantifying nucleic acids.
$26.4M
Mar 03, 2016
Series A
-
Biodesy develops a novel system to analyze real-time protein function for research and clinical applications.
$10M
Jan 20, 2016
Series B
-

These are all the companies that Roche has invested in. Roche has invested 18 companies and its latest investment was Promedior, Inc. in Nov 2019. Promedior is a clinical-stage biotechnology company that develops and commercializes novel therapeutics for the treatment of fibrotic disorders.

Roche News

March 29, 2020Medical Buyer

Roche Gets Nod To Import Diagnostic Kits In India; Supply To Begin Soon

Swiss pharmaceutical major Roche, which received the Emergency Use Authorisation for its novel corona... See more »
March 27, 2020The Business Journals: San Jose

$110M injection powers up Peninsula vaccine maker - but not for COVID-19

Aiming to beat big-name competition with a super-powered pneumonia vaccine, SutroVax Inc. raised $110... See more »
March 27, 2020STAT News

Roche backpedals and agrees to provide a solution for Covid-19 tests in the Netherlands

In a startling about-face, Roche has agreed to release the recipe for a liquid solution that Dutch la... See more »
March 27, 2020The Pharma Letter

Roche targets children with Xofluza following 'hardest-hitting influenza' season

Swiss pharma giant Roche has announced that the US Food and Drug Administration (FDA) has accepted a.... See more »
March 27, 2020BioPortfolio

FDA accepts Roches New Drug Application for Xofluza baloxavir marboxil for the treatment of influenza in children

Basel 27 March Â2020 Roche SIX RO ROG; OTCQX RHHBY today announced that the US Food and Drug Administ... See more »
March 27, 2020Xconomy

Forge Inks Roche Deal For Antibiotic Aimed at Drug-Resistant Infections

Forge Therapeutics has set an agreement with Roche that gives the Swiss pharma giant the option to li... See more »
March 26, 2020FinSMEs

SutroVax Raises $110M in Series D Financing

SutroVax, a Foster City, Calif.-based biopharmaceutical company dedicated to the delivery of novel va... See more »

Roche Press Releases

September 30, 2019firstwordpharma

Roche's Tecentriq cuts risk of disease progression by 18% in previously untreated advanced bladder cancer

Results presented Monday at the European Society for Medical Oncology (ESMO) congress showed that the... See more »
September 25, 2019PR Newswire

West Cancer Center and Research Institute partners with Roche Tissue Diagnostics - Enhancing Patient Care in the Histology Laboratory with Automation

MEMPHIS, Tenn., Sept. 25, 2019 /PRNewswire/ -- West Clinic Cancer Center is holding a ribbon cutting ... See more »
September 3, 2019GlobeNewswire

Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc.

Basel, 3 September 2019 - Roche (SIX: RO, ROG; OTCQX: RHHBY) and Spark Therapeutics, Inc. (NASDAQ: ON... See more »
June 26, 2019PRWeb

Roche UK Deploys LifeLink Chatbot as Next Generation Medical Information Desk Virtual Assistant

Conversational Messaging Bot Supports FAQs and Collects Adverse Event Data, Achieving 91% User Satisf... See more »
March 14, 2019PR Newswire

Infinity To Initiate MARIO-3, A Phase 2 Multi-Arm Study Evaluating IPI-549 In Front-Line Triple Negative Breast Cancer And Renal Cell Cancer

CAMBRIDGE, Mass., March 14, 2019 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today ... See more »
December 11, 2018streetinsider

Roche to develop companion diagnostic test to help identify patients eligible for anti-PD-1 therapy based on biomarker expression, not location, of solid tumors

TUCSON, Ariz., Dec. 11, 2018 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that ... See more »
December 11, 2018centralcharts

Roche to develop companion diagnostic test to help identify patients eligible for anti-PD-1 therapy based on biomarker expression, not location, of solid tumors

TUCSON, Ariz., Dec. 11, 2018 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that ... See more »

Roche Videos

January 15, 2020Roche Youtube Channel

""It's about our own life..." I Believe that you can recover! Episode 4" on YOUTUBE

See more »
December 20, 2019Roche Youtube Channel

"Light at the end of the tunnel | Dan's liver cancer story" on YOUTUBE

See more »
December 12, 2019Roche Youtube Channel

"Changing the way we think about breast cancer | My Shade of Pink" on YOUTUBE

See more »
November 25, 2019Roche Youtube Channel

"Marielle Gallegos Ruiz: Outcome data personalized healthcare" on YOUTUBE

See more »
November 16, 2019Roche Youtube Channel

"MS Practical Tips | Keep your brain active" on YOUTUBE

See more »
October 25, 2019Roche Youtube Channel

"Reimaging breast cancer | With a new palette of pink" on YOUTUBE

See more »
October 22, 2019Roche Youtube Channel

"The history of a diagnosis | About multiple sclerosis, with Florence and Simona" on YOUTUBE

See more »

Social Statistics

Headquarters

Grenzacherstrasse 124

Basel, Basel-Country4070

41-61-688-1111

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

F. Hoffman- La Roche Ltd or simply Roche (Six Swiss Exchange, ROG) discovers, develops, and provides diagnostics and therapeutic products and services. Founded in 1986, the company has its headquarters in Basel, Switzerland. With 14 biopharmaceuticals...

CEO

Roche's CEO, Severin Schwan, currently has an approval rating of 65%. Roche's primary competitors are Novartis, Merck & Bristol Myers Squibb.

Website

roche.com

Frequently Asked Questions about Roche

  1. When was Roche founded?

    Roche was founded in 1896

  2. Who is Roche's CEO?

    Roche's CEO is Severin Schwan

  3. How much revenue does Roche generate?

    Roche generates $63.3B in revenue

  4. How much funding does Roche have?

    Roche has historically raised $0 in funding

  5. Where is Roche's headquarters?

    Roche's headquarters is in Basel Basel-Country, CH

  1. How many employees does Roche have?

    Roche has 98,000 employees

  2. What sector does Roche operate in?

    Roche is in Biotechnology

  3. Who are Roche's competitors?

    Roche's top competitors are Novartis, Merck, Bristol Myers Squibb

  4. Who has Roche invested in?

    Roche's has invested in companies such as Amunix, Biodesy, Second Genome
Stay up-to-date with the latest news on Roche